Tag Archives: Private Credit

CVC Credit provides debt facilities to smartTrade through its European Direct Lending strategy

CVC Capital Partners

CVC Credit is pleased to announce that it has provided debt facilities to support the acquisition and growth strategy of smartTrade Technologies (“smartTrade”), a global SaaS platform providing multi-asset trading and payment software, owned by TA Associates.

Headquartered in Southern France, with subsidiaries in London, Paris, Geneva, New York, Toronto, Tokyo and Singapore, smartTrade provides essential FX trading software used for order management, trade execution and post-trade support. It boasts a global blue chip client base of large, regional and local banks, brokerages and corporations.

This investment has been made through CVC Credit’s European Direct Lending strategy, which focuses on lending to established European medium and large companies, with a focus on the senior secured piece of the capital structure.

Eva Boutillier, Managing Director at CVC Credit, said: “We are delighted to announce this latest transaction for our European Direct Lending strategy, leveraging the broader CVC Network’s expertise in the software sector to diligence smartTrade and gain comfort around the business’s strong fundamentals, attractive market and ambitious growth strategy.

Quotes

smartTrade is exactly the type of business we like to invest in through this strategy, with strong existing market positioning but also a large addressable market to allow for further future growth.

Andrew DaviesManaging Partner and Head of CVC Private Credit

Andrew Davies, Managing Partner and Head of CVC Private Credit, added: “smartTrade is exactly the type of business we like to invest in through this strategy, with strong existing market positioning but also a large addressable market to allow for further future growth. We are also pleased to strengthen our relationship with TA Associates, a high-quality sponsor that has experience investing in this sector.”

Categories: News

Tags:

L&G and Blackstone Announce Strategic Partnership to Accelerate Growth Ambitions

Blackstone

LONDON, UK and NEW YORK, US – 10 July 2025 – Today, Legal & General (L&G, LSE:LGEN) and Blackstone (NYSE:BX) are announcing a long-term strategic partnership that combines the strength of L&G and Blackstone’s respective credit platforms to enhance L&G’s competitive advantage in annuities and bolster its asset management proposition in key geographies and channels.

L&G’s annuities business will leverage Blackstone’s private credit origination platform to access a pipeline of diversified investment-grade assets, predominantly from the US. This partnership will complement L&G’s existing capabilities to gain competitive advantage, enhanced returns, and support its growth ambitions. L&G will invest up to 10% of anticipated annuities new business flows. This will add to the $237 billion in third-party insurance assets Blackstone manages across investment-grade private credit, liquid credit, and other strategies.[1]

Additionally, L&G’s asset management business will develop public/private hybrid credit solutions that combine Blackstone’s leading private credit platform with L&G’s best-in-class active fixed income capabilities. This will accelerate L&G’s ambitions to expand into highly attractive global wealth and wholesale channels.

The partnership combines L&G’s leading positions in pension risk transfer and asset management – comprising a $122.5 billion (£92 billion) annuities book and $1.4 trillion (£1.1 trillion) in assets under management[2] – with the strength and scale of Blackstone’s $465 billion credit platform.

Antonio Simões, Group CEO, L&G said: “Today’s announcement marks another important step in delivering our strategy for focused, sustainable growth and enhanced shareholder returns. Complementing L&G’s own insurance, investment and asset origination capabilities, our partnership with Blackstone will further cement our market leading position in pension risk transfer, and enable us to address growing demand for public-private hybrid investment products. L&G will benefit from a more diverse pipeline of assets for our annuity book, and growth in asset management as we develop more sophisticated investment solutions for clients around the world.”

Jon Gray, President and Chief Operating Officer, Blackstone said: “We’re thrilled to partner with L&G, a world-class firm with strong performance that we have long admired. Blackstone has been a pioneer in bringing the benefits of private markets investing to insurance companies, individuals and institutional investors. Together, our two firms’ unmatched scale and expertise should drive innovative solutions in the private credit market.”

Eric Adler, CEO, Asset Management, L&G said: “In June, we set out our vision as a leading global investor innovating to solve client challenges, using the power of L&G. This partnership brings together the combined strengths of L&G and Blackstone’s respective credit businesses, to offer new, innovative investment solutions and extend our international reach. I am especially energised by the potential of our alliance to advance our proposition in global wealth and wholesale channels, and deepen the capabilities we can draw upon to support our institutional clients.”

Philip Sherrill, Global Head of Insurance, Blackstone said: “We believe this partnership shows the best of what Blackstone can offer to our insurance company clients. The breadth of our capabilities allows us to support our partners across their businesses – originating assets, working together to identify investment opportunities, and designing products that meet the needs of both institutional clients and individual investors.”

About Blackstone Credit & Insurance
Blackstone Credit & Insurance (“BXCI”) is one of the world’s leading credit investors. Our investments span the credit markets, including private investment grade, asset-based lending, public investment grade and high yield, sustainable resources, infrastructure debt, collateralized loan obligations, direct lending and opportunistic credit. We seek to generate attractive risk-adjusted returns for institutional and individual investors by offering companies capital needed to strengthen and grow their businesses. BXCI is also a leading provider of investment management services for insurers, helping those companies better deliver for policyholders through our world-class capabilities in investment grade private credit.

About L&G
Established in 1836, L&G is one of the UK’s leading financial services groups and a major global investor, with £1.1 trillion in total assets under management (as at FY24) of which c. 44% (c. £0.5 trillion) is international.

We have a highly synergistic business model, which continues to drive strong returns. We are a leading player in Institutional Retirement, in Retail Savings and Protection, and in Asset Management through both public and private markets. Across the Group, we are committed to responsible investing and dedicated to serving the long-term savings and investment needs of customers and society.

Forward-Looking Statements
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which reflect Blackstone’s current views with respect to, among other things, its operations, taxes, earnings and financial performance and the strategic partnership referred to herein. You can identify these forward-looking statements by the use of words such as “outlook,” “indicator,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “seeks,” “approximately,” “predicts,” “intends,” “plans,” “scheduled,” “estimates,” “anticipates,” “opportunity,” “leads,” “forecast,” “possible” or the negative version of these words or other comparable words. Such forward-looking statements are subject to various risks and uncertainties. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. Blackstone believes these factors include but are not limited to those described under the section entitled “Risk Factors” in its Annual Report on Form 10-K for the year ended December 31, 2024, as such factors may be updated from time to time in its periodic filings with the United States Securities and Exchange Commission (“SEC”), which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in its other periodic filings. The forward-looking statements speak only as of the date of this release, and Blackstone undertakes no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise.

FURTHER INFORMATION:

Blackstone
Felix Lettau
Felix.Lettau@blackstone.com
+44 20 7104 4562

L&G
Sneha Patel
sneha.patel@group.landg.com
+44 75536 04804

Headland Consultancy
Lucy Legh
landg@headlandconsultancy.com

[1] As of March 31, 2025
[2] FX conversion rate as at YE 2024

Categories: News

Tags:

Carlyle Provides Financing to Support TPG’s $1.1 Billion Carve-Out of Sabre’s Hospitality Solutions Business

Carlyle

New York, NY – July 8, 2025 – Global investment firm Carlyle (NASDAQ: CG) today announced that its Global Credit platform has led a $400 million financing to support TPG’s recently completed acquisition of Sabre Corporation’s Hospitality Solutions (“Hospitality Solutions”) business. The transaction established Hospitality Solutions as an independent hospitality technology company.

Hospitality Solutions provides software and solutions to more than 40% of the world’s leading hotel brands. The SaaS based platform serves as an integrated system of record for reservation and guest information, enabling hoteliers to operate with greater accuracy and efficiency.

Carlyle’s financing will support TPG’s investment in the newly independent business as it accelerates growth, executes on new product development initiatives, and continues the onboarding of major global customers.

“We’re proud to support TPG in establishing Hospitality Solutions as an independent technology leader with a strong foundation and clear path for growth,” said Kunal Gulati, Deputy Chief Investment Officer of Carlyle Direct Lending. “This transaction reflects our ability to deliver tailored capital solutions at scale to support our partner sponsors and management teams leading strategic transformations.”

Carlyle’s Global Credit platform manages $199 billion in assets under management, as of March 31, 2025. It regularly pursues investments in privately negotiated debt and capital solutions partnering with high-quality sponsors and leading family or entrepreneur-owned companies.

About Carlyle

Carlyle (NASDAQ: CG) is a global investment firm with deep industry expertise that deploys private capital across three business segments: Global Private Equity, Global Credit, and Carlyle AlpInvest. With $453 billion of assets under management as of March 31, 2025, Carlyle’s purpose is to invest wisely and create value on behalf of its investors, portfolio companies, and the communities in which we live and invest. Carlyle employs more than 2,300 people in 29 offices across four continents. Further information is available at www.carlyle.com. Follow Carlyle on X @OneCarlyle and LinkedIn at The Carlyle Group.

Media Contact:

Kristen Ashton
+1 212-813-4763
kristen.ashton@carlyle.com

Categories: News

Tags:

Coller Capital Raises Record $6.8 Billion for Private Credit Secondaries Platform

Coller Capital

  • The landmark closing of Coller Credit Opportunities II underscores Coller Capital’s leadership and scale in private credit secondaries
  • CCO II targets senior direct lending and performing credit investments, pursuing opportunities across both LP-led and GP-led secondary transactions
  • To date the firm has now committed $10.1bn to credit secondaries

London and New York, 8 July 2025 – Coller Capital, the world’s largest dedicated private market secondaries manager, today announces the final closing of Coller Credit Opportunities II (“CCO II”), bringing a record total of $6.8 billion raised for Coller’s credit platform in its latest fundraising cycle. Coller’s credit platform includes commingled funds, co-investment vehicles, separately managed accounts, and its credit-focused perpetual funds.

The successful capital raise follows the firm’s pioneering $1.4 billion first credit fund, CCO I, which previously set the benchmark as the largest private credit secondaries fund at the time. Coller Capital’s robust fundraising reflects its established global presence, innovative approach, and deep specialist expertise in secondaries.

CCO II targets senior direct lending and high-quality performing credit investments across LP-led and GP-led opportunities. The fund seeks to deliver strong risk-adjusted returns and stable, resilient performance through market cycles by providing investors diversified exposure to premium credit assets.

The private credit secondaries market has grown substantially, driven by increasing investor demand for liquidity solutions, diversification, and sophisticated portfolio management tools. Coller Capital has seen $53bn of secondary credit investment opportunities since January 2024, with substantial growth anticipated as more private credit funds mature.

Michael Schad, Partner, Head of Coller Credit Secondaries, said: “This record-setting fundraise reinforces Coller Capital’s status as the preeminent investor in private credit secondaries. Our disciplined, credit-centric investment strategy, combined with our ability to execute complex transactions at scale, continues to resonate with global investors seeking defensive, diversified strategies. With increased market participation and liquidity demand, we anticipate continued strong activity in LP-led and GP-led transactions throughout 2025 and beyond.”

Jeremy Coller, Chief Investment Officer and Managing Partner of Coller Capital, commented: “Coller Credit Opportunities II is a milestone fundraise that reaffirms the significant evolution and maturation of the private credit secondaries market. Investors increasingly recognize the strategic importance of private credit secondaries in achieving defensive exposure, liquidity, and enhanced portfolio management amid heightened market volatility. Coller Capital’s global platform, specialist knowledge, and proven track record uniquely position us as the partner of choice for investors around the world.

“The success of this fundraise is a testament to the quality of Coller’s entire global team and the trust our partners place in us, as well as the track record of our credit leaders Michael Schad, Ed Goldstein, and Martins Marnauza who have been investing together for more than 14 years.”

Coller Capital was an early mover in credit secondaries, pioneering investments as early as 2008. To date the firm has now committed $10.1bn to the space.

Coller Capital’s leading market position is exemplified by recent landmark transactions, including the acquisition of a $1.6 billion senior direct lending portfolio from American National, one of the largest-ever LP-led credit secondaries transactions. Additionally, in 2024, Coller Capital created the industry’s largest credit continuation vehicle to date, underwriting a $1.6bn portfolio managed by Abry Partners.

Mentions
Black and white formal headshot of Michael Schad.

Michael Schad

Partner, Head of Coller Credit Secondaries
Black and white formal headshot of Ed Goldstein.

Ed Goldstein

Partner, CIO of Coller Credit Secondaries
Black and white formal headshot of Martins Marnauza.

Martins Marnauza

Partner, Investment
Black and white formal headshot of Jeremy Coller.

Jeremy Coller

Chief Investment Officer and Managing Partner
Press contact
Edelman Smithfield

coller@edelmansmithfield.com+44 (0)7980 684 247

Categories: News

Tags:

Apollo Commits to £4.5 Billion Financing for Électricité de France, Marking the Largest Sterling-Denominated Private Credit Transaction

Apollo logo

Proceeds to primarily finance EDF projects in the UK, notably the Hinkley Point C nuclear power station

NEW YORK, June 20, 2025 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that Apollo-managed affiliates, funds, and strategic accounts have signed an agreement to invest up to £4.5 billion in fixed-rate callable notes issued by Électricité de France (“EDF”) pursuant to its €50 billion Euro Medium Term Note (“EMTN”) program. Proceeds from the financing will be used primarily to finance EDF projects in the United Kingdom, most notably the Hinkley Point C nuclear power station. This transaction represents one of the largest sterling-denominated note issuances on record.

Apollo Partner Jamshid Ehsani said, “Apollo is pleased to provide this bespoke, large-scale financing to EDF in support of its vital role in advancing European energy sovereignty and power infrastructure, including in the UK.”

Ehsani continued, “This landmark transaction highlights our deepening partnership with the French government and EDF and reaffirms our commitment to being a premier capital provider to leading European companies. This is the largest-ever capital funding transaction executed by EDF and the largest private credit transaction in the sterling market.”

This investment also builds on Apollo’s longstanding history of investing in French companies for nearly three decades. Notably, Apollo has provided €2.5 billion of High-Grade Capital Solutions across three transactions to Air France-KLM in recent years.

Since 2020, under its High-Grade Capital Solutions strategy, Apollo has originated over $100 billion of bespoke capital solutions for leading companies such as Intel, Air France-KLM, BP, Sony, AB InBev, Vonovia, and more.

Latham & Watkins, LLP and Kirkland & Ellis LLP acted as legal counsel to Apollo while Apollo Capital Solutions Europe B.V. is providing structuring and arrangement services in connection with the transaction. BNP Paribas and Hogan Lovells, LLP acted as financial and legal advisors, respectively, to EDF.

About Apollo
Apollo is a high-growth, global alternative asset manager. In our asset management business, we seek to provide our clients excess return at every point along the risk-reward spectrum from investment grade credit to private equity. For more than three decades, our investing expertise across our fully integrated platform has served the financial return needs of our clients and provided businesses with innovative capital solutions for growth. Through Athene, our retirement services business, we specialize in helping clients achieve financial security by providing a suite of retirement savings products and acting as a solutions provider to institutions. Our patient, creative, and knowledgeable approach to investing aligns our clients, businesses we invest in, our employees, and the communities we impact, to expand opportunity and achieve positive outcomes. As of March 31, 2025, Apollo had approximately $785 billion of assets under management. To learn more, please visit www.apollo.com.

Apollo Contacts

Noah Gunn
Global Head of Investor Relations
Apollo Global Management, Inc.
(212) 822-0540
IR@apollo.com

Joanna Rose
Global Head of Corporate Communications
Apollo Global Management, Inc.
(212) 822-0491
Communications@apollo.com / europeanmedia@apollo.com

Categories: News

Tags:

Bridgepoint prices reset of Bridgepoint CLO V

Bridgepoint prices reset of Bridgepoint CLO V

Bridgepoint has today announced the successful pricing of the reset of Bridgepoint CLO V.

The transaction extends the investment period to 2030 and lowers the cost of capital of the original 2023 deal.

Bridgepoint’s third CLO transaction of 2025, the reset saw strong demand throughout the full capital stack, evidencing the market’s continued appetite for Bridgepoint’s disciplined approach to investment and credit selection.

Commenting on the transaction, John Murphy, Partner and Bridgepoint’s Head of Syndicated Debt, said:

“We’re pleased to have seen such strong continued interest from our broader investor base with the reset of Bridgepoint CLO V. By combining a long-term reinvestment horizon with a flexible, high-conviction approach to portfolio management, we’ve shown our platform can adapt to changing markets and unlock consistent value. This robust investor demand speaks to the trust placed in our differentiated approach.”

With more than €14 billion of assets under management in corporate credit across the risk/reward spectrum, Bridgepoint Credit is one of Europe’s most experienced credit managers. It focuses on three complementary investment strategies: Direct Lending, Credit Opportunities and Syndicated Debt.

Bridgepoint Group is one of the world’s leading quoted private asset growth investors, specialising in private equity, infrastructure and private credit.

With over $86 billion of assets under management and a strong local presence in Europe, North America and Asia, we combine global scale with local market insight and sector expertise, consistently delivering strong returns through cycles.

Bridgepoint Advisers Limited, a subsidiary of Bridgepoint Group plc, is authorised and regulated by the Financial Conduct Authority.

Categories: News

Tags:

Coller Capital expands global reach through strategic partnership with Allfunds

Coller Capital

  • The partnership will distribute CollerEquity and CollerCredit to accredited private investors, wealth managers and family offices.
  • It will provide global individual investors with access to institutional-quality private equity and credit secondaries, enabling them to benefit from the liquidity and resilience that private markets secondaries afford.

London 6th June 2025 – Coller Capital, the world’s largest dedicated private market secondaries manager, has today announced a global distribution partnership with Allfunds, the leading end-to-end WealthTech partner for the wealth and asset management industries with more than $1.5 trillion assets under administration across Mutual Funds, Alternative Assets and ETFs. This global partnership will see Coller Private Equity Secondaries (CollerEquity) and Coller Private Credit Secondaries (CollerCredit) made available to the 19,000 accredited private investors, wealth managers and family offices on the Allfunds platform.

CollerEquity launched in July 2024. The Fund’s portfolio consists of institutional quality private equity assets diversified by GP-manager, and fund vintage as well as by geography and sector. Alongside diversification, the Fund seeks to deliver a combination of absolute and risk-adjusted returns and the opportunity for more liquidity than traditional private equity funds.

CollerCredit launched in October 2024. The portfolio is diversified across vintages, managers, industrial sectors and geography. While its core focus is on senior direct lending opportunities, it has the flexibility to invest across other credit strategies opportunistically if risk-adjusted returns and liquidity profiles are deemed to be appropriate.

Both CollerEquity and CollerCredit and its regional feeder funds are available to professional and qualified investors in a range of global jurisdictions, including across Europe, the Middle East, Canada, Asia, and Australia in compliance with local law. The Funds’ clients are supported by Coller’s Private Wealth Secondaries Solutions (PWSS) team, which now consists of 50 dedicated professionals supported by the wider Coller platform. Both Funds provide investors with access to Coller Capital’s 35 years of secondaries investment expertise and its global platform. They offer monthly subscriptions and quarterly redemptions, and can be accessed with USD 50,000 minimum commitment.

Jake Elmhirst, Partner, Head of Private Wealth Secondaries Solutions and Deputy Head of Capital Formation at Coller Capital, said: “Coller Capital has a long-standing reputation for innovation in private markets secondaries, and that spirit drives our wealth strategy. The strategic investment approach underpinning CollerEquity and CollerCredit provides investors with diversified, risk-adjusted returns, as well as portfolio resilience in times of wider market dislocation. This partnership with Allfunds widens the spectrum of investors who have access to these benefits, and we look forward to working with their team.”

Boris Maeder, Managing Director and Head of International Private Wealth Distribution at Coller Capital, said: “Through this global partnership with Allfunds, we are making CollerEquity and CollerCredit more accessible to a wider range of investors. It represents a meaningful step in broadening access to private equity and private credit secondaries, which are powerful tools for portfolio diversification, liquidity and resilience – including in times of wider market uncertainty.”

Borja Largo, Chief Fund Groups Officer for Allfunds said: “This partnership with Coller Capital unlocks exciting new access to private market secondaries for our clients, strengthening Allfunds’ position as the largest and most comprehensive marketplace for wealth and asset management solutions. We remain dedicated to continuously enhancing our private markets offering to empower our clients and help them grow.”

Coller Capital has offices in London, New York, Hong Kong, Beijing, Seoul, Luxembourg, Zurich, Melbourne, Montreal and Singapore. The firm manages $40 billion in secondaries across private equity, private credit, and other private market vehicles and has 35 years of experience in the secondary private capital market.

About Coller Private Equity Secondaries – (“CollerEquity”) and Coller Private Credit Secondaries (“CollerCredit”)

THIS IS A MARKETING COMMUNICATION IN RESPECT OF THE FUND. PLEASE REFER TO THE PROSPECTUS, KEY INFORMATION DOCUMENT, GOVERNING AND OTHER RELEVANT DOCUMENTS FOR THE FUND BEFORE MAKING ANY INVESTMENT DECISION

Potential investors should be aware that an investment in the CollerEquity and/or CollerCredit (including any related overflow, co-investment, or other vehicles, the “Funds”) is speculative and involves a high degree of risk, and is suitable only for those investors who have the financial sophistication and expertise to evaluate the merits and risks of an investment in the Fund(s) and for which such Fund(s) do(es) not represent a complete investment program. An investment should only be considered by persons who can afford a loss of their entire investment. The following is a summary of only certain considerations and is qualified in its entirety by the more detailed risks and conflicts in the CollerEquity and CollerCredit prospectuses. Investors are urged to consult with their own tax and legal advisors about the implications of investing in the Fund. Fees and expenses can be expected to reduce the overall return of the Fund.

Investors should carefully consider the investment objectives, risks, charges and expenses of CollerEquity and/or CollerCredit. This and other important information about the Funds are contained in the relevant prospectus. Please read the prospectus(es) carefully before investing. The CollerEquity Prospectus can be found here. The CollerCredit Prospectus can be found here.

General Risks. Coller Capital cannot ensure that it can choose, make and realize investments in any particular investment fund or portfolio of investment funds. There is no assurance CollerEquity and/or CollerCredit will be able to generate returns for the investors or that returns will be commensurate with the risks of investing in the type of companies and investments in which CollerEquity and/or CollerCredit may indirectly invest. An investment in CollerEquity and/or CollerCredit should only be considered by persons who can afford a loss of their entire investment. There can be no assurance that CollerEquity and/or CollerCredit’s investment objectives will be achieved or that investors will receive a return on their capital. Any investment in CollerEquity and/or CollerCredit entails risks, including but not limited to the risk of losing all or part of the amount invested. There can be no assurance that CollerEquity and/or CollerCredit will be able to implement its investment strategy or achieve its investment objectives.

Specific risks: Lack of Operating History. Diversification. Competition. Limited Current Return. Illiquidity; Transfer Restrictions. Leverage. Exchange Rate Fluctuations.

Performance is generally subject to taxation which depends on the particular situation of each investor and which may change in the future. The operating or chosen currency of an investor may also impact upon returns that may be realised by that investor.

Capital is at risk and investors may not receive back the amount they invest. The strategy of the Funds does not guarantee a profit or ensure protection against losses. There can be no assurance that the Funds will achieve their objectives or avoid significant losses.

Mentions
Black and white formal headshot of Jake Elmhirst.
Jake Elmhirst

Partner, Head of Private Wealth Secondaries Solutions and Deputy Head of Capital Formation
Black and white formal headshot of Boris Maeder.
Boris Maeder

Managing Director and Head of International Private Wealth Distribution
Press contact
Edelman Smithfield

coller@edelmansmithfield.com+44 (0)7980 684 247

News
6 Ju

Categories: News

Tags:

Antares Closes $1.2 Billion Private Credit Continuation Vehicle Led by Ares Management

Antares
CHICAGO & NEW YORK–(BUSINESS WIRE)– Antares Capital and Ares Management Corporation (“Ares”) (NYSE: ARES) today announced the closing of Antares’ first continuation vehicle with over $1.2 billion in commitments. The transaction was led by Ares Credit Secondaries funds, along with a commitment from Antares.

The continuation vehicle was established to purchase assets and limited partner interests from two comingled private credit funds comprising over 100 underlying first lien, floating rate loans originated and managed by Antares. The vehicle provided existing investors with an attractive liquidity option while offering new investors exposure to quality Antares-originated private credit assets.

“This transaction underscores our strong, long-standing partnership with Ares and our shared commitment to providing quality private credit opportunities,” said Vivek Mathew, president of Antares Capital Advisers. “It also marks an important step in expanding the Antares platform and delivering new liquidity solutions to our investors.”

“We are pleased to welcome Ares as a lead investor and believe the successful close of our first continuation vehicle in today’s dynamic market highlights the quality of the Antares portfolio and the power of our origination and underwriting capabilities,” said Ben Chapin, Head of Liquidity Solutions at Antares Capital. “We are committed to structuring differentiated liquidity options tailored to both LPs and GPs, leveraging our extensive private credit experience, deep relationships and focus on credit discipline.”

“Building upon our multidecade relationship with Antares, we are proud to lead this transaction, which represents Ares’ largest credit secondary investment to date,” said Dave Schwartz, Head of Credit Secondaries, Ares. “This investment underscores our team’s differentiated experience in private credit and secondaries and our ability to deploy scaled capital. We look forward to leveraging our global relationships with leading private credit managers to deliver creative liquidity solutions that meet the needs of investors.”

Evercore served as exclusive financial advisor on the transaction.

About Antares Capital
Founded in 1996, Antares has been a leader in private credit for nearly three decades. Today with approximately $80 billion* of capital under management and administration as of December 31, 2024, Antares is an experienced and cycle-tested alternative credit manager. With one of the most seasoned teams in the industry, Antares is focused on delivering attractive risk-adjusted returns for investors and creating long term value for all of its partners. The firm maintains offices in Atlanta, Chicago, Los Angeles, New York, Toronto and London. Visit Antares at www.antares.com or follow the company on LinkedIn at https://www.linkedin.com/company/antares-capital-lp.

Antares Capital is a subsidiary of Antares Holdings LP, (collectively, “Antares”). Antares Capital London Limited is an appointed representative of Langham Hall Fund Management LLP, an entity which is authorized and regulated by the Financial Conduct Authority of the UK.

*As of December 31, 2024, all figures are estimates and subject to change upon finalization.

About Ares Management Corporation
Ares Management Corporation (NYSE: ARES) is a leading global alternative investment manager offering clients complementary primary and secondary investment solutions across the credit, real estate, private equity and infrastructure asset classes. We seek to provide flexible capital to support businesses and create value for our stakeholders and within our communities. By collaborating across our investment groups, we aim to generate consistent and attractive investment returns throughout market cycles. As of March 31, 2025, Ares Management Corporation’s global platform had approximately $546 billion of assets under management, with operations across North America, South America, Europe, Asia Pacific and the Middle East. For more information, please visit www.aresmgmt.com.

Antares
Allison Perkins
allison.perkins@antares.com

Ares
Jacob Silber | Lauren Sullivan
media@aresmgmt.com

Source: Antares Capital

Back to Media

Categories: News

Tags:

KKR Provides $600 Million Financing to Indian Conglomerate Manipal Group

KKR

Transaction marks KKR’s latest and largest credit investment in India

MUMBAI, India–(BUSINESS WIRE)– KKR, a leading global investment firm, and Manipal Education and Medical Group (“MEMG” or “Manipal Group”), a major diversified conglomerate in India, today announced a $600-million financing arranged by KKR Capital Markets and anchored by KKR’s private credit and insurance platforms to the Manipal Group. The investment will enable the Manipal Group to accelerate its corporate expansion and growth objectives by providing flexible, structured capital matched to its long-term strategic needs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250601919977/en/

The Manipal Group is a leading conglomerate in India with various institutions and major businesses across the healthcare, education, and health insurance sectors, including Manipal Health Enterprises, one of India’s top multispecialty hospitals chains in India.

KKR’s Asia Pacific Credit platform seeks to provide, among other private credit strategies, bespoke solutions to high-quality companies, entrepreneurs, promoters and sponsors that harness the strength of KKR’s private markets investment capabilities and its expertise as one of the largest alternative credit managers globally.

Gaurav Trehan, Co-Head of KKR Asia Pacific and Head of Asia Private Equity, KKR said, “We are pleased to deepen our relationship with the Manipal Group and Dr Ranjan Pai, who have established one of India’s pre-eminent and homegrown businesses, as they continue to deliver on their long-term vision. The Manipal Group has built a strong reputation over the decades as one of India’s healthcare and education leaders, and we look forward to supporting and contributing to their continued success.”

Dr. Ranjan Pai, Chairman of Manipal Education and Medical Group, said, “We are proud to welcome KKR as a strategic partner as we continue to build on Manipal’s legacy in healthcare and education. KKR’s longstanding India focus and flexible capital approach, as well as alignment with our long-term vision, present a strong fit for us.”

Diane Raposio, Partner and Head of Asia Credit and Markets at KKR, added, “This transaction underscores the strength of our global credit platform and our ability to provide strategic, scaled capital solutions to leading businesses. India is a priority market for our credit strategy, and we look to build on this momentum to be a partner of choice to more high-quality companies like Manipal on their growth ambitions.”

KKR is making its investment from its Asia Pacific Credit strategy and insurance platform. Since 2019, KKR has committed more than $8 billion across around 60 credit investments under its Asia Pacific Credit strategy, accounting for a total transaction volume of more than $21 billion.

Additional details of the transaction are not disclosed.

About KKR

KKR is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR aims to generate attractive investment returns by following a patient and disciplined investment approach, employing world-class people, and supporting growth in its portfolio companies and communities. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds. KKR’s insurance subsidiaries offer retirement, life and reinsurance products under the management of Global Atlantic Financial Group. References to KKR’s investments may include the activities of its sponsored funds and insurance subsidiaries. For additional information about KKR & Co. Inc. (NYSE: KKR), please visit KKR’s website at www.kkr.com. For additional information about Global Atlantic Financial Group, please visit Global Atlantic Financial Group’s website at www.globalatlantic.com.

About Manipal Education and Medical Group (MEMG)

Founded in 1953 by Padma Shri Dr TMA Pai, MEMG has evolved into a diversified conglomerate, with a strong presence in healthcare, education and health insurance in India and globally. MEMG’s operations touch the lives of over 20 million people annually with Manipal Hospitals scaling up to become the largest tertiary network in India. MEMG’s flagship University, Manipal Academy of Higher Education has been recognized as an Institute of Eminence by the Government of India. Claypond Capital, the family office of Dr. Pai and the investing arm of MEMG has been one of the more prolific investing family offices in India in the last 18 months. Their marquee investments include Aakash, BPL Medical, BlueStone, Easy Home Finance, First Cry, Finnable, InCred Finance, NSE, Panacea Medical, PharmEasy, Purpple, Recykal, SSI Innovations and Zepto.

Media Contacts

For KKR Asia Pacific
Wei Jun Ong
+65 6922 5813
WeiJun.Ong@kkr.com

For Manipal Group
Shyam Powar
+91 98804 75000
Shyam.Powar@claypondcapital.com

Source: KKR

 

Download PDF

Categories: News

Tags:

Axsome Therapeutics Enters $570 Million Term Loan and Revolving Credit Facility with Blackstone

Blackstone

Previous term loan facility retired

NEW YORK – May 13, 2025 – Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it has entered into a $570 million term loan and revolving credit facility with funds managed by Blackstone Life Sciences and Blackstone Credit & Insurance (“Blackstone”). Concurrent with this new facility, Axsome has retired its previous term loan with Hercules Capital. The improved financial terms and expected use of the new facility are expected to result in a significant reduction in interest expense.

“The new agreement with Blackstone simultaneously expands our total available credit facility by more than $200 million, and significantly reduces our cost of capital,” said Herriot Tabuteau, MD, Chief Executive Officer of Axsome Therapeutics. “We are pleased to partner with the Blackstone team given their differentiated expertise in the life sciences industry. The improved terms of the new facility underscore our commitment to accelerating time to profitability and enhancing shareholder value, while advancing our mission to improve the lives of patients living with serious CNS disorders.”

“Blackstone is proud to partner with Axsome at a time of growth and expanding commercial opportunity,” said Craig Shepherd and Kiran Reddy, MD, Senior Managing Directors with Blackstone Life Sciences. “This investment is designed to reinforce the company’s operational and financial agility to support its next phase of growth, and it is a testament to Blackstone’s ability to deliver customized and flexible financing solutions to help leading biopharma companies achieve their strategic objectives.”

Brad Colman, Global Head of Healthcare with Blackstone Credit & Insurance, added, “Axsome’s proven commercial success, innovative pipeline, and strong leadership team make it an ideal partner as we continue to invest in transformative therapies to help patients. This transaction exemplifies how we can provide scaled credit solutions to world-class life sciences companies.”

The new $570 million facility consists of a $500 million term loan facility and a $70 million revolving credit facility. Upon closing of the agreement, the Company drew down a total of $120 million from the term loan facility which was used to retire the previous term loan with Hercules Capital. Under the terms of the new term loan facility, an additional $250 million may be drawn at the Company’s option, with an additional $200 million available subject to the approval of Blackstone. The facility bears interest at a calculated SOFR variable rate plus 4.75% for the term loan, and SOFR variable rate plus 4.0% for the revolving credit facility. The facility matures in May 2030 and has an interest-only payment period of 60 months. Concurrent with the closing of the agreement, Blackstone purchased $15 million of Axsome common stock at the 30-day volume weighted average price per share equal to $107.14.

Additional details regarding the financing agreement are available in the Company’s Form 8-K to be filed with the Securities and Exchange Commission.

About Axsome Therapeutics
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Our industry-leading neuroscience portfolio includes FDA-approved treatments for major depressive disorder, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine, and multiple late-stage development programs addressing a broad range of serious neurological and psychiatric conditions that impact over 150 million people in the United States. Together, we are on a mission to solve some of the brain’s biggest problems so patients and their loved ones can flourish. For more information, please visit us at www.axsome.com and follow us on LinkedIn and X.

About Blackstone Life Sciences
Blackstone Life Sciences (BXLS) is an industry-leading private investment platform with capabilities to invest across the life cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, BXLS helps bring to market promising new medicines and medical technologies that improve patients’ lives and currently has $12 billion in assets under management.

About Blackstone Credit & Insurance
Blackstone Credit & Insurance (“BXCI”) is one of the world’s leading credit investors. Our investments span the credit markets, including private investment grade, asset-based lending, public investment grade and high yield, sustainable resources, infrastructure debt, collateralized loan obligations, direct lending and opportunistic credit. We seek to generate attractive risk-adjusted returns for institutional and individual investors by offering companies capital needed to strengthen and grow their businesses. BXCI is also a leading provider of investment management services for insurers, helping those companies better deliver for policyholders through our world-class capabilities in investment grade private credit.

Forward Looking Statements
Certain matters discussed in this press release are “forward-looking statements”. The Company may, in some cases, use terms such as “predicts,” “believes,” “potential,” “continue,” “estimates,” “anticipates,” “expects,” “plans,” “intends,” “may,” “could,” “might,” “will,” “should” or other words that convey uncertainty of future events or outcomes to identify these forward-looking statements. In particular, the Company’s statements regarding trends and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the commercial success of the Company’s SUNOSI®, AUVELITY®, and SYMBRAVO® products and the success of the Company’s efforts to obtain any additional indication(s) with respect to solriamfetol and/or AXS-05; the Company’s ability to maintain and expand payer coverage; the success, timing and cost of the Company’s ongoing clinical trials and anticipated clinical trials for the Company’s current product candidates, including statements regarding the timing of initiation, pace of enrollment and completion of the trials (including the Company’s ability to fully fund the Company’s disclosed clinical trials, which assumes no material changes to the Company’s currently projected revenues or expenses), futility analyses and receipt of interim results, which are not necessarily indicative of the final results of the Company’s ongoing clinical trials, and/or data readouts, and the number or type of studies or nature of results necessary to support the filing of a new drug application (“NDA”) for any of the Company’s current product candidates; the Company’s ability to fund additional clinical trials to continue the advancement of the Company’s product candidates; the timing of and the Company’s ability to obtain and maintain U.S. Food and Drug Administration (“FDA”) or other regulatory authority approval of, or other action with respect to, the Company’s product candidates, including statements regarding the timing of any NDA submission; the Company’s ability to successfully defend its intellectual property or obtain the necessary licenses at a cost acceptable to the Company, if at all; the successful implementation of the Company’s research and development programs and collaborations; the success of the Company’s license agreements; the acceptance by the market of the Company’s products and product candidates, if approved; the Company’s anticipated capital requirements, including the amount of capital required for the commercialization of SUNOSI, AUVELITY, and SYMBRAVO and for the Company’s commercial launch of its other product candidates, if approved, and the potential impact on the Company’s anticipated cash runway; the Company’s ability to convert sales to recognized revenue and maintain a favorable gross to net sales; unforeseen circumstances or other disruptions to normal business operations arising from or related to domestic political climate, geo-political conflicts or a global pandemic and other factors, including general economic conditions and regulatory developments, not within the Company’s control. The factors discussed herein could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Axsome Contacts:

Investors:
Mark Jacobson
Chief Operating Officer
(212) 332-3243
mjacobson@axsome.com

Media:
Darren Opland
Director, Corporate Communications
(929) 837-1065
dopland@axsome.com

Blackstone:
David Vitek
(212) 583-5291
David.Vitek@blackstone.com

Categories: News

Tags: